Kandavel Shanmugam - Concepedia

Author

Kandavel Shanmugam

Ventana Research Corporation (United States)ORCID

Also Known As

Clare Verrill, K Shanmugam, K. S. Shanmugam, K. Shanmugam, Kandavel Shanmugam, Shanmugam K

177

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Ventana Research Corporation (United States)Mayo Clinic in Arizona Mayo Clinic McGill University Inserm

About

Kandavel Shanmugam is an author at Ventana Research Corporation (United States) specializing in medicine, gene expression, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	754
2	Natural Sciences	4	4	329
3	Cell Biology	4	4	423
4	Biostatistics	1	1	26
5	Hepatology	1	1	99

Kandavel Shanmugam

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
MUC1 enhances invasiveness of pancreatic cancer cells by inducing epithelial to mesenchymal transition Lopamudra Das Roy, Mahnaz Sahraei, Durai B. Subramani, Oncogene Tumor BiologyOncologyPancreatic CancerMedicinePancreatic Cancer Cells	2010	265
PBX and MEIS as Non-DNA-Binding Partners in Trimeric Complexes with HOX Proteins Kandavel Shanmugam, Nancy C. Green, Isabel Rambaldi, Molecular and Cellular Biology Protein AssemblyGeneticsMolecular BiologyMolecular GeneticsNon-dna-binding Partners	1999	168
Validation of <i>HER2</i> Amplification as a Predictive Biomarker for Anti–Epidermal Growth Factor Receptor Antibody Therapy in Metastatic Colorectal Cancer Kanwal Pratap Singh Raghav, Jonathan M. Loree, Jeffrey S. Morris, JCO Precision Oncology	2019	126
Platelet-Derived Growth Factor Receptor β–Mediated Phosphorylation of MUC1 Enhances Invasiveness in Pancreatic Adenocarcinoma Cells Pankaj K. Singh, Yunfei Wen, Benjamin J. Swanson, Cancer Research	2007	107
GIV/Girdin is a central hub for profibrogenic signalling networks during liver fibrosis Inmaculada López-Sánchez, Ying Dunkel, Yoon-Seok Roh, Nature Communications FibrosisSignal TransductionHepatologyLiver FibrosisSignaling Pathway	2014	99
Phosphorylation of MUC1 by Met Modulates Interaction with p53 and MMP1 Expression Pankaj K. Singh, Michelle Behrens, John P. Eggers, Journal of Biological Chemistry	2008	87
Intertumoral Heterogeneity of CD3+ and CD8+ T-Cell Densities in the Microenvironment of DNA Mismatch-Repair–Deficient Colon Cancers: Implications for Prognosis Harry H. Yoon, Qian Shi, Erica N. Heying, Clinical Cancer Research	2018	81
HER2 amplification as a negative predictive biomarker for anti-epidermal growth factor receptor antibody therapy in metastatic colorectal cancer. Kanwal Raghav, Michael J. Overman, Ruoxi Yu, Journal of Clinical Oncology Tumor BiologyNegative Predictive BiomarkerCancer EpidemiologyKras WildtypeGastrointestinal Oncology	2016	73
Mutation‐specific antibody detects mutant BRAF<sup>V600E</sup> protein expression in human colon carcinomas Frank A. Sinicrope, Thomas C. Smyrk, David Tougeron, Cancer	2013	65
A mutant BRAF V600E-specific immunohistochemical assay: correlation with molecular mutation status and clinical outcome in colorectal cancer Fiona Day, Andrea Murányi, Shalini Singh, Targeted Oncology	2014	54

Page 1